{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T02:48:55Z","timestamp":1790909335803,"version":"4.1.0"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:00:00Z","timestamp":1743638400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:00:00Z","timestamp":1743638400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Cancer"],"DOI":"10.1038\/s43018-025-00935-0","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T17:08:23Z","timestamp":1743786503000},"page":"718-735","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Adoptively transferred tumor-specific IL-9-producing cytotoxic CD8+ T cells activate host CD4+ T cells to control tumors with antigen loss"],"prefix":"10.1038","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3013-4523","authenticated-orcid":false,"given":"Liuling","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5124-9338","authenticated-orcid":false,"given":"Wendao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanchao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingzhe","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-6001-1077","authenticated-orcid":false,"given":"Miao","family":"Xian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6141-0068","authenticated-orcid":false,"given":"Qiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8087-5047","authenticated-orcid":false,"given":"Wei","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pan","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingqun","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yabo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfei","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0077-0040","authenticated-orcid":false,"given":"Yong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3477-0914","authenticated-orcid":false,"given":"Zhongming","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1529-3398","authenticated-orcid":false,"given":"Qing","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,3]]},"reference":[{"key":"935_CR1","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/nrclinonc.2016.25","volume":"13","author":"DN Khalil","year":"2016","unstructured":"Khalil, D. N., Smith, E. L., Brentjens, R. J. & Wolchok, J. D. The future of cancer treatment: immunomodulation, CARs and combination immunotherapy. Nat. Rev. Clin. Oncol. 13, 273\u2013290 (2016).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"935_CR2","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00281-018-0703-z","volume":"41","author":"O Met","year":"2019","unstructured":"Met, O., Jensen, K. M., Chamberlain, C. A., Donia, M. & Svane, I. M. Principles of adoptive T cell therapy in cancer. Semin. Immunopathol. 41, 49\u201358 (2019).","journal-title":"Semin. Immunopathol."},{"key":"935_CR3","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1126\/science.aaa4967","volume":"348","author":"SA Rosenberg","year":"2015","unstructured":"Rosenberg, S. A. & Restifo, N. P. Adoptive cell transfer as personalized immunotherapy for human cancer. Science 348, 62\u201368 (2015).","journal-title":"Science"},{"key":"935_CR4","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1126\/science.abb9847","volume":"370","author":"S Krishna","year":"2020","unstructured":"Krishna, S. et al. Stem-like CD8 T cells mediate response of adoptive cell immunotherapy against human cancer. Science 370, 1328\u20131334 (2020).","journal-title":"Science"},{"key":"935_CR5","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1056\/NEJMoa1609279","volume":"375","author":"E Tran","year":"2016","unstructured":"Tran, E. et al. T-cell transfer therapy targeting mutant KRAS in cancer. N. Engl. J. Med. 375, 2255\u20132262 (2016).","journal-title":"N. Engl. J. Med."},{"key":"935_CR6","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1056\/NEJMoa1610497","volume":"375","author":"CE Brown","year":"2016","unstructured":"Brown, C. E. et al. Regression of glioblastoma after chimeric antigen receptor T-cell therapy. N. Engl. J. Med. 375, 2561\u20132569 (2016).","journal-title":"N. Engl. J. Med."},{"key":"935_CR7","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/nature11538","volume":"490","author":"J Landsberg","year":"2012","unstructured":"Landsberg, J. et al. Melanomas resist T-cell therapy through inflammation-induced reversible dedifferentiation. Nature 490, 412\u2013416 (2012).","journal-title":"Nature"},{"key":"935_CR8","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1126\/science.aaa4971","volume":"348","author":"TN Schumacher","year":"2015","unstructured":"Schumacher, T. N. & Schreiber, R. D. Neoantigens in cancer immunotherapy. Science 348, 69\u201374 (2015).","journal-title":"Science"},{"key":"935_CR9","doi-asserted-by":"publisher","first-page":"5400","DOI":"10.1172\/JCI126199","volume":"129","author":"SR Walsh","year":"2019","unstructured":"Walsh, S. R. et al. Endogenous T cells prevent tumor immune escape following adoptive T cell therapy. J. Clin. Invest. 129, 5400\u20135410 (2019).","journal-title":"J. Clin. Invest."},{"key":"935_CR10","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/nrclinonc.2015.215","volume":"13","author":"P Savas","year":"2016","unstructured":"Savas, P. et al. Clinical relevance of host immunity in breast cancer: from TILs to the clinic. Nat. Rev. Clin. Oncol. 13, 228\u2013241 (2016).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"935_CR11","doi-asserted-by":"publisher","first-page":"4309","DOI":"10.1158\/1078-0432.CCR-16-0903","volume":"22","author":"RM Chabanon","year":"2016","unstructured":"Chabanon, R. M. et al. Mutational landscape and sensitivity to immune checkpoint blockers. Clin. Cancer Res. 22, 4309\u20134321 (2016).","journal-title":"Clin. Cancer Res."},{"key":"935_CR12","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/s41586-019-1032-7","volume":"567","author":"R Rosenthal","year":"2019","unstructured":"Rosenthal, R. et al. Neoantigen-directed immune escape in lung cancer evolution. Nature 567, 479\u2013485 (2019).","journal-title":"Nature"},{"key":"935_CR13","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/nrc.2017.74","volume":"17","author":"M Yarchoan","year":"2017","unstructured":"Yarchoan, M., Johnson, B. A. 3rd, Lutz, E. R., Laheru, D. A. & Jaffee, E. M. Targeting neoantigens to augment antitumour immunity. Nat. Rev. Cancer 17, 569 (2017).","journal-title":"Nat. Rev. Cancer"},{"key":"935_CR14","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1056\/NEJMoa1406498","volume":"371","author":"A Snyder","year":"2014","unstructured":"Snyder, A. et al. Genetic basis for clinical response to CTLA-4 blockade in melanoma. N. Engl. J. Med. 371, 2189\u20132199 (2014).","journal-title":"N. Engl. J. Med."},{"key":"935_CR15","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/nm.3161","volume":"19","author":"PF Robbins","year":"2013","unstructured":"Robbins, P. F. et al. Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells. Nat. Med. 19, 747\u2013752 (2013).","journal-title":"Nat. Med."},{"key":"935_CR16","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1158\/2326-6066.CIR-13-0027","volume":"2","author":"LC Wang","year":"2014","unstructured":"Wang, L. C. et al. Targeting fibroblast activation protein in tumor stroma with chimeric antigen receptor T cells can inhibit tumor growth and augment host immunity without severe toxicity. Cancer Immunol. Res. 2, 154\u2013166 (2014).","journal-title":"Cancer Immunol. Res."},{"key":"935_CR17","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/s41586-019-1671-8","volume":"574","author":"E Alspach","year":"2019","unstructured":"Alspach, E. et al. MHC-II neoantigens shape tumour immunity and response to immunotherapy. Nature 574, 696\u2013701 (2019).","journal-title":"Nature"},{"key":"935_CR18","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/nature14426","volume":"520","author":"S Kreiter","year":"2015","unstructured":"Kreiter, S. et al. Mutant MHC class II epitopes drive therapeutic immune responses to cancer. Nature 520, 692\u2013696 (2015).","journal-title":"Nature"},{"key":"935_CR19","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1084\/jem.20130590","volume":"211","author":"X Fan","year":"2014","unstructured":"Fan, X., Quezada, S. A., Sepulveda, M. A., Sharma, P. & Allison, J. P. Engagement of the ICOS pathway markedly enhances efficacy of CTLA-4 blockade in cancer immunotherapy. J. Exp. Med. 211, 715\u2013725 (2014).","journal-title":"J. Exp. Med."},{"key":"935_CR20","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1038\/s41586-023-06199-x","volume":"618","author":"B Kruse","year":"2023","unstructured":"Kruse, B. et al. CD4+ T cell-induced inflammatory cell death controls immune-evasive tumours. Nature 618, 1033\u20131040 (2023).","journal-title":"Nature"},{"key":"935_CR21","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.tcb.2020.06.003","volume":"30","author":"M St Paul","year":"2020","unstructured":"St Paul, M. & Ohashi, P. S. The roles of CD8+ T cell subsets in antitumor immunity. Trends Cell Biol. 30, 695\u2013704 (2020).","journal-title":"Trends Cell Biol."},{"key":"935_CR22","doi-asserted-by":"publisher","first-page":"e153247","DOI":"10.1172\/JCI153247","volume":"132","author":"L Xiao","year":"2022","unstructured":"Xiao, L. et al. IL-9\/STAT3\/fatty acid oxidation-mediated lipid peroxidation contributes to Tc9 cell longevity and enhanced antitumor activity. J. Clin. Invest. 132, e153247 (2022).","journal-title":"J. Clin. Invest."},{"key":"935_CR23","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1073\/pnas.1317431111","volume":"111","author":"Y Lu","year":"2014","unstructured":"Lu, Y. et al. Tumor-specific IL-9-producing CD8+ Tc9 cells are superior effector than type-I cytotoxic Tc1 cells for adoptive immunotherapy of cancers. Proc. Natl Acad. Sci. USA 111, 2265\u20132270 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"935_CR24","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.immuni.2012.09.018","volume":"38","author":"SY Chang","year":"2013","unstructured":"Chang, S. Y. et al. Circulatory antigen processing by mucosal dendritic cells controls CD8+ T cell activation. Immunity 38, 153\u2013165 (2013).","journal-title":"Immunity"},{"key":"935_CR25","doi-asserted-by":"publisher","first-page":"4055","DOI":"10.3892\/etm.2016.3870","volume":"12","author":"W Wang","year":"2016","unstructured":"Wang, W., Cheng, Z. S., Chen, Y. F. & Lin, Y. H. Increased circulating IL-9-producing CD8+ T cells are associated with eosinophilia and high FeNO in allergic asthmatics. Exp. Ther. Med. 12, 4055\u20134060 (2016).","journal-title":"Exp. Ther. Med."},{"key":"935_CR26","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nrc3239","volume":"12","author":"DM Pardoll","year":"2012","unstructured":"Pardoll, D. M. The blockade of immune checkpoints in cancer immunotherapy. Nat. Rev. Cancer 12, 252\u2013264 (2012).","journal-title":"Nat. Rev. Cancer"},{"key":"935_CR27","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1158\/2159-8290.CD-17-1178","volume":"8","author":"A Mehta","year":"2018","unstructured":"Mehta, A. et al. Immunotherapy resistance by inflammation-induced dedifferentiation. Cancer Discov. 8, 935\u2013943 (2018).","journal-title":"Cancer Discov."},{"key":"935_CR28","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1084\/jem.20171576","volume":"215","author":"X Ma","year":"2018","unstructured":"Ma, X. et al. Cholesterol negatively regulates IL-9-producing CD8+ T cell differentiation and antitumor activity. J. Exp. Med. 215, 1555\u20131569 (2018).","journal-title":"J. Exp. Med."},{"key":"935_CR29","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.cell.2019.02.005","volume":"177","author":"M Binnewies","year":"2019","unstructured":"Binnewies, M. et al. Unleashing type-2 dendritic cells to drive protective antitumor CD4+ T cell immunity. Cell 177, 556\u2013571 (2019).","journal-title":"Cell"},{"key":"935_CR30","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1016\/j.cell.2020.05.017","volume":"181","author":"DY Oh","year":"2020","unstructured":"Oh, D. Y. et al. Intratumoral CD4+ T cells mediate anti-tumor cytotoxicity in human bladder cancer. Cell 181, 1612\u20131625 (2020).","journal-title":"Cell"},{"key":"935_CR31","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41586-018-0130-2","volume":"557","author":"Y Simoni","year":"2018","unstructured":"Simoni, Y. et al. Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates. Nature 557, 575\u2013579 (2018).","journal-title":"Nature"},{"key":"935_CR32","doi-asserted-by":"publisher","first-page":"e20200921","DOI":"10.1084\/jem.20200921","volume":"218","author":"LE Lucca","year":"2021","unstructured":"Lucca, L. E. et al. Circulating clonally expanded T cells reflect functions of tumor-infiltrating T cells. J. Exp. Med. 218, e20200921 (2021).","journal-title":"J. Exp. Med."},{"key":"935_CR33","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1146\/annurev-immunol-032712-095954","volume":"31","author":"SN Mueller","year":"2013","unstructured":"Mueller, S. N., Gebhardt, T., Carbone, F. R. & Heath, W. R. Memory T cell subsets, migration patterns, and tissue residence. Annu. Rev. Immunol. 31, 137\u2013161 (2013).","journal-title":"Annu. Rev. Immunol."},{"key":"935_CR34","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1126\/science.1251102","volume":"344","author":"E Tran","year":"2014","unstructured":"Tran, E. et al. Cancer immunotherapy based on mutation-specific CD4+ T cells in a patient with epithelial cancer. Science 344, 641\u2013645 (2014).","journal-title":"Science"},{"key":"935_CR35","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41577-018-0088-1","volume":"19","author":"SC Eisenbarth","year":"2019","unstructured":"Eisenbarth, S. C. Dendritic cell subsets in T cell programming: location dictates function. Nat. Rev. Immunol. 19, 89\u2013103 (2019).","journal-title":"Nat. Rev. Immunol."},{"key":"935_CR36","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.immuni.2013.08.028","volume":"39","author":"Y Gao","year":"2013","unstructured":"Gao, Y. et al. Control of T helper 2 responses by transcription factor IRF4-dependent dendritic cells. Immunity 39, 722\u2013732 (2013).","journal-title":"Immunity"},{"key":"935_CR37","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/nri.2016.116","volume":"17","author":"T Worbs","year":"2017","unstructured":"Worbs, T., Hammerschmidt, S. I. & Forster, R. Dendritic cell migration in health and disease. Nat. Rev. Immunol. 17, 30\u201348 (2017).","journal-title":"Nat. Rev. Immunol."},{"key":"935_CR38","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1038\/s41590-020-0676-7","volume":"21","author":"J Lai","year":"2020","unstructured":"Lai, J. et al. Adoptive cellular therapy with T cells expressing the dendritic cell growth factor Flt3L drives epitope spreading and antitumor immunity. Nat. Immunol. 21, 914\u2013926 (2020).","journal-title":"Nat. Immunol."},{"key":"935_CR39","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/j.immuni.2013.04.011","volume":"38","author":"A Schlitzer","year":"2013","unstructured":"Schlitzer, A. et al. IRF4 transcription factor-dependent CD11b+ dendritic cells in human and mouse control mucosal IL-17 cytokine responses. Immunity 38, 970\u2013983 (2013).","journal-title":"Immunity"},{"key":"935_CR40","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/ni.2795","volume":"15","author":"B Vander Lugt","year":"2014","unstructured":"Vander Lugt, B. et al. Transcriptional programming of dendritic cells for enhanced MHC class II antigen presentation. Nat. Immunol. 15, 161\u2013167 (2014).","journal-title":"Nat. Immunol."},{"key":"935_CR41","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1111\/j.1365-2567.2005.02094.x","volume":"114","author":"M Wang","year":"2005","unstructured":"Wang, M. & Liang, P. Interleukin-24 and its receptors. Immunology 114, 166\u2013170 (2005).","journal-title":"Immunology"},{"key":"935_CR42","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1158\/1541-7786.MCR-07-0344","volume":"6","author":"L Xu","year":"2008","unstructured":"Xu, L. et al. Gene expression changes in an animal melanoma model correlate with aggressiveness of human melanoma metastases. Mol. Cancer Res. 6, 760\u2013769 (2008).","journal-title":"Mol. Cancer Res."},{"key":"935_CR43","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman, A. M. et al. Robust enumeration of cell subsets from tissue expression profiles. Nat. Methods 12, 453\u2013457 (2015).","journal-title":"Nat. Methods"},{"key":"935_CR44","doi-asserted-by":"publisher","first-page":"eaai7677","DOI":"10.1126\/sciimmunol.aai7677","volume":"1","author":"GF Heidkamp","year":"2016","unstructured":"Heidkamp, G. F. et al. Human lymphoid organ dendritic cell identity is predominantly dictated by ontogeny, not tissue microenvironment. Sci. Immunol. 1, eaai7677 (2016).","journal-title":"Sci. Immunol."},{"key":"935_CR45","doi-asserted-by":"publisher","first-page":"eaah4573","DOI":"10.1126\/science.aah4573","volume":"356","author":"AC Villani","year":"2017","unstructured":"Villani, A. C. et al. Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors. Science 356, eaah4573 (2017).","journal-title":"Science"},{"key":"935_CR46","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1016\/j.ccell.2021.09.011","volume":"39","author":"G Xue","year":"2021","unstructured":"Xue, G. et al. Adoptive cell therapy with tumor-specific Th9 cells induces viral mimicry to eliminate antigen-loss-variant tumor cells. Cancer Cell 39, 1610\u20131622 (2021).","journal-title":"Cancer Cell"},{"key":"935_CR47","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/s41591-020-01225-1","volume":"27","author":"NB Nagarsheth","year":"2021","unstructured":"Nagarsheth, N. B. et al. TCR-engineered T cells targeting E7 for patients with metastatic HPV-associated epithelial cancers. Nat. Med. 27, 419\u2013425 (2021).","journal-title":"Nat. Med."},{"key":"935_CR48","doi-asserted-by":"publisher","first-page":"eaat8549","DOI":"10.1126\/scitranslmed.aat8549","volume":"11","author":"AE Zamora","year":"2019","unstructured":"Zamora, A. E. et al. Pediatric patients with acute lymphoblastic leukemia generate abundant and functional neoantigen-specific CD8+ T cell responses. Sci. Transl. Med. 11, eaat8549 (2019).","journal-title":"Sci. Transl. Med."},{"key":"935_CR49","doi-asserted-by":"publisher","first-page":"5697","DOI":"10.1158\/0008-5472.CAN-11-0103","volume":"71","author":"M Chmielewski","year":"2011","unstructured":"Chmielewski, M., Kopecky, C., Hombach, A. A. & Abken, H. IL-12 release by engineered T cells expressing chimeric antigen receptors can effectively muster an antigen-independent macrophage response on tumor cells that have shut down tumor antigen expression. Cancer Res. 71, 5697\u20135706 (2011).","journal-title":"Cancer Res."},{"key":"935_CR50","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.immuni.2005.02.003","volume":"22","author":"A Corthay","year":"2005","unstructured":"Corthay, A. et al. Primary antitumor immune response mediated by CD4+ T cells. Immunity 22, 371\u2013383 (2005).","journal-title":"Immunity"},{"key":"935_CR51","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nm.3773","volume":"21","author":"C Linnemann","year":"2015","unstructured":"Linnemann, C. et al. High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4+ T cells in human melanoma. Nat. Med. 21, 81\u201385 (2015).","journal-title":"Nat. Med."},{"key":"935_CR52","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.ccell.2020.05.002","volume":"37","author":"MK Ruhland","year":"2020","unstructured":"Ruhland, M. K. et al. Visualizing synaptic transfer of tumor antigens among dendritic cells. Cancer Cell 37, 786\u2013799 (2020).","journal-title":"Cancer Cell"},{"key":"935_CR53","doi-asserted-by":"publisher","first-page":"e145885","DOI":"10.1172\/jci.insight.145885","volume":"6","author":"S Iwanowycz","year":"2021","unstructured":"Iwanowycz, S. et al. Type 2 dendritic cells mediate control of cytotoxic T cell resistant tumors. JCI Insight 6, e145885 (2021).","journal-title":"JCI Insight"},{"key":"935_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13720","volume":"7","author":"D Laoui","year":"2016","unstructured":"Laoui, D. et al. The tumour microenvironment harbours ontogenically distinct dendritic cell populations with opposing effects on tumour immunity. Nat. Commun. 7, 13720 (2016).","journal-title":"Nat. Commun."},{"key":"935_CR55","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.ccell.2016.06.003","volume":"30","author":"EW Roberts","year":"2016","unstructured":"Roberts, E. W. et al. Critical role for CD103+\/CD141+ dendritic cells bearing CCR7 for tumor antigen trafficking and priming of T cell immunity in melanoma. Cancer Cell 30, 324\u2013336 (2016).","journal-title":"Cancer Cell"},{"key":"935_CR56","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.immuni.2016.03.012","volume":"44","author":"H Salmon","year":"2016","unstructured":"Salmon, H. et al. Expansion and activation of CD103+ dendritic cell progenitors at the tumor site enhances tumor responses to therapeutic PD-L1 and BRAF Inhibition. Immunity 44, 924\u2013938 (2016).","journal-title":"Immunity"},{"key":"935_CR57","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1002\/eji.201242825","volume":"43","author":"A Visekruna","year":"2013","unstructured":"Visekruna, A. et al. Tc9 cells, a new subset of CD8+ T cells, support Th2-mediated airway inflammation. Eur. J. Immunol. 43, 606\u2013618 (2013).","journal-title":"Eur. J. Immunol."},{"key":"935_CR58","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41392-020-00380-8","volume":"6","author":"Q Hu","year":"2021","unstructured":"Hu, Q. et al. IL-24 armored CAR19-T cells show enhanced antitumor activity and persistence. Signal Transduct. Target. Ther. 6, 14 (2021).","journal-title":"Signal Transduct. Target. Ther."},{"key":"935_CR59","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1158\/0008-5472.CAN-20-2604","volume":"81","author":"Z Liu","year":"2021","unstructured":"Liu, Z. et al. Engineering T cells to express tumoricidal MDA-7\/IL24 enhances cancer immunotherapy. Cancer Res. 81, 2429\u20132441 (2021).","journal-title":"Cancer Res."},{"key":"935_CR60","doi-asserted-by":"publisher","first-page":"3244","DOI":"10.4049\/jimmunol.178.5.3244","volume":"178","author":"V Steenwinckel","year":"2007","unstructured":"Steenwinckel, V. et al. IL-13 mediates in vivo IL-9 activities on lung epithelial cells but not on hematopoietic cells. J. Immunol. 178, 3244\u20133251 (2007).","journal-title":"J. Immunol."},{"key":"935_CR61","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1016\/j.molcel.2022.01.020","volume":"82","author":"C Zhang","year":"2022","unstructured":"Zhang, C. et al. Micropeptide PACMP inhibition elicits synthetic lethal effects by decreasing CtIP and poly(ADP-ribosyl)ation. Mol. Cell 82, 1297\u20131312 (2022).","journal-title":"Mol. Cell"},{"key":"935_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23946-8","volume":"12","author":"LG Lima","year":"2021","unstructured":"Lima, L. G. et al. Tumor microenvironmental cytokines bound to cancer exosomes determine uptake by cytokine receptor-expressing cells and biodistribution. Nat. Commun. 12, 3543 (2021).","journal-title":"Nat. Commun."},{"key":"935_CR63","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/j.1365-2249.2012.04642.x","volume":"170","author":"S Hong","year":"2012","unstructured":"Hong, S. et al. Optimizing dendritic cell vaccine for immunotherapy in multiple myeloma: tumour lysates are more potent tumour antigens than idiotype protein to promote anti-tumour immunity. Clin. Exp. Immunol. 170, 167\u2013177 (2012).","journal-title":"Clin. Exp. Immunol."},{"key":"935_CR64","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1038\/s41591-018-0085-8","volume":"24","author":"KC Barry","year":"2018","unstructured":"Barry, K. C. et al. A natural killer\u2013dendritic cell axis defines checkpoint therapy-responsive tumor microenvironments. Nat. Med. 24, 1178\u20131191 (2018).","journal-title":"Nat. Med."},{"key":"935_CR65","doi-asserted-by":"publisher","first-page":"101945","DOI":"10.1016\/j.xpro.2022.101945","volume":"4","author":"L Xiao","year":"2022","unstructured":"Xiao, L. & Yi, Q. Isolation of adoptively transferred CD8+ T cells in mouse tumor tissues for lipid peroxidation detection. STAR Protoc. 4, 101945 (2022).","journal-title":"STAR Protoc."},{"key":"935_CR66","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.cels.2018.02.010","volume":"6","author":"S Chevrier","year":"2018","unstructured":"Chevrier, S. et al. Compensation of signal spillover in suspension and imaging mass cytometry. Cell Syst. 6, 612\u2013620 (2018).","journal-title":"Cell Syst."},{"key":"935_CR67","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/nprot.2015.020","volume":"10","author":"ER Zunder","year":"2015","unstructured":"Zunder, E. R. et al. Palladium-based mass tag cell barcoding with a doublet-filtering scheme and single-cell deconvolution algorithm. Nat. Protoc. 10, 316\u2013333 (2015).","journal-title":"Nat. Protoc."},{"key":"935_CR68","doi-asserted-by":"publisher","first-page":"748","DOI":"10.12688\/f1000research.11622.1","volume":"6","author":"M Nowicka","year":"2017","unstructured":"Nowicka, M. et al. CyTOF workflow: differential discovery in high-throughput high-dimensional cytometry datasets. F1000Res. 6, 748 (2017).","journal-title":"F1000Res."},{"key":"935_CR69","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/nbt.2594","volume":"31","author":"AD Amir el","year":"2013","unstructured":"Amir el, A. D. et al. viSNE enables visualization of high dimensional single-cell data and reveals phenotypic heterogeneity of leukemia. Nat. Biotechnol. 31, 545\u2013552 (2013).","journal-title":"Nat. Biotechnol."},{"key":"935_CR70","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/nri.2016.56","volume":"16","author":"Y Saeys","year":"2016","unstructured":"Saeys, Y., Van Gassen, S. & Lambrecht, B. N. Computational flow cytometry: helping to make sense of high-dimensional immunology data. Nat. Rev. Immunol. 16, 449\u2013462 (2016).","journal-title":"Nat. Rev. Immunol."},{"key":"935_CR71","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/ijo.2015.145","volume":"40","author":"L Xiao","year":"2016","unstructured":"Xiao, L. et al. Large adipocytes function as antigen-presenting cells to activate CD4+ T cells via upregulating MHCII in obesity. Int. J. Obes. (Lond.) 40, 112\u2013120 (2016).","journal-title":"Int. J. Obes. (Lond.)"},{"key":"935_CR72","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19672-2","volume":"11","author":"L Liu","year":"2020","unstructured":"Liu, L. et al. Enhanced CAR-T activity against established tumors by polarizing human T cells to secrete interleukin-9. Nat. Commun. 11, 5902 (2020).","journal-title":"Nat. Commun."},{"key":"935_CR73","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573\u20133587 (2021).","journal-title":"Cell"},{"key":"935_CR74","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","volume":"16","author":"I Korsunsky","year":"2019","unstructured":"Korsunsky, I. et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat. Methods 16, 1289\u20131296 (2019).","journal-title":"Nat. Methods"},{"key":"935_CR75","first-page":"100141","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu, T. et al. clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innovation (Camb.) 2, 100141 (2021).","journal-title":"Innovation (Camb.)"},{"key":"935_CR76","doi-asserted-by":"publisher","first-page":"47","DOI":"10.12688\/f1000research.22139.1","volume":"9","author":"N Borcherding","year":"2020","unstructured":"Borcherding, N., Bormann, N. L. & Kraus, G. scRepertoire: an R-based toolkit for single-cell immune receptor analysis. F1000Res. 9, 47 (2020).","journal-title":"F1000Res."},{"key":"935_CR77","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.cell.2018.01.004","volume":"172","author":"JP Bottcher","year":"2018","unstructured":"Bottcher, J. P. et al. NK cells stimulate recruitment of cDC1 into the tumor microenvironment promoting cancer immune control. Cell 172, 1022\u20131037 (2018).","journal-title":"Cell"},{"key":"935_CR78","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.cmet.2021.02.015","volume":"33","author":"X Ma","year":"2021","unstructured":"Ma, X. et al. CD36-mediated ferroptosis dampens intratumoral CD8+ T cell effector function and impairs their antitumor ability. Cell Metab. 33, 1001\u20131012 (2021).","journal-title":"Cell Metab."},{"key":"935_CR79","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/leu.2017.193","volume":"32","author":"Q Wang","year":"2018","unstructured":"Wang, Q. et al. Therapeutic effects of CSF1R-blocking antibodies in multiple myeloma. Leukemia 32, 176\u2013183 (2018).","journal-title":"Leukemia"}],"container-title":["Nature Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43018-025-00935-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43018-025-00935-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43018-025-00935-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T06:02:16Z","timestamp":1745820136000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43018-025-00935-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,3]]},"references-count":79,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["935"],"URL":"https:\/\/doi.org\/10.1038\/s43018-025-00935-0","relation":{},"ISSN":["2662-1347"],"issn-type":[{"value":"2662-1347","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,3]]},"assertion":[{"value":"18 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}